Journal of Proteomics & Bioinformatics
Open Access
ISSN: 0974-276X
ISSN: 0974-276X
Kevin Camphausen
Radiation Oncology Branch
National Cancer Institute
National Institutes of Health
Bethesda
Maryland
USA
Kevin Camphausen received his undergraduate degree from Purdue University in 1988. He then completed his MD (1996) and medical internship (1997) at Georgetown University Medical Center. He next completed his residency in radiation oncology at the Joint Center of Radiation Therapy at Harvard Medical School (2001). While there, he worked in the laboratory of Dr. Judah Folkman studying the interactions of antiangiogenic therapy and radiotherapy. He joined the Radiation Oncology Branch in 2001 as a tenure track investigator, received tenure in 2007 and was promoted to Chief of the Radiation Oncology Branch (ROB), Center for Cancer Research (CCR), NCI. He is a physician/scientist who has a laboratory program focusing on the development and characterization of agents that alter the tumoral response to radiation. He has been successful in translating his work from the laboratory to the clinic. Dr. Camphausen is an internationally recognized leader in his field and an expert in the field of drug-induced tumor radiosensitization including the use of anti-angiogenic agents in combination with radiotherapy.
Radiotherapy, Glioblastoma Multiforme, HDAC, Radiation Sensitizers, Biomarkers,Prostate Cancer